Guidance for Mirum Pharmaceuticals, Inc. (MIRM)
| Period | Range | Estimate | Revenue Range | Revenue Estimate | Target | Details |
|---|---|---|---|---|---|---|
| 2025 | N/A | N/A | $500.00M – 510.00M | $506.70M | = Maintained | Details |
| 2025 | N/A | N/A | $435.00M – 450.00M | $427.80M | = Maintained | Details |
| 2024 | N/A | N/A | $330.00M – 335.00M | $316.30M | = Maintained | Details |
| 2024 | N/A | N/A | $310.00M – 320.00M | $312.70M | = Maintained | Details |
| 2024 | N/A | N/A | $310.00M – 320.00M | $316.40M | = Maintained | Details |
| 2024 | N/A | N/A | $310.00M – 320.00M | $316.40M | = Maintained | Details |
